| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 07/06/2006 | US20060147375 Antibodies and related molecules that bind to PSCA proteins |
| 07/06/2006 | US20060147374 Compositions and methods for the diagnosis and treatment of tumor |
| 07/06/2006 | US20060147373 Compositions and methods for the diagnosis and treatment of tumor |
| 07/06/2006 | DE102004060385A1 Verfahren zur Bestimmung entzündlicher Vorgänge und pharmazeutische Zusammensetzungen zur Behandlung derselben A method for determining inflammatory processes and pharmaceutical compositions for treatment of the same |
| 07/06/2006 | CA2594253A1 Treatment for cutaneous metastases |
| 07/06/2006 | CA2594224A1 Methods to elicit, enhance and sustain immune responses against mhc class i-restricted epitopes, for prophylactic or therapeutic purposes |
| 07/06/2006 | CA2593035A1 Pharmaceutical compositions for treating diseases associated with nf-.kappa.b activity |
| 07/06/2006 | CA2592972A1 Methods to bypass cd+4 cells in the induction of an immune response |
| 07/06/2006 | CA2592968A1 Use of compositions comprising various tumor-associated antigens as anti-cancer vaccines |
| 07/06/2006 | CA2592922A1 Methods to trigger, maintain and manipulate immune responses by targeted administration of biological response modifiers into lymphoid organs |
| 07/06/2006 | CA2592323A1 Stabilization of viral compositions |
| 07/06/2006 | CA2592141A1 Virus preparations and methods |
| 07/06/2006 | CA2592118A1 Enzyme modulators and treatments |
| 07/06/2006 | CA2592015A1 Orally deliverable and anti-toxin antibodies and methods for making and using them |
| 07/06/2006 | CA2591059A1 Monoclonal antibodies against nkg2a |
| 07/06/2006 | CA2590441A1 Immunoglobulins comprising predominantly a ga1glcnacman5glcnac2 glycoform |
| 07/06/2006 | CA2589374A1 Antibodies directed to gpnmb and uses thereof |
| 07/06/2006 | CA2553788A1 Immunoglobulins whith potent and broad antiviral activity |
| 07/05/2006 | EP1677113A1 Method for the identification of protein-protein interactions in disease related protein networks |
| 07/05/2006 | EP1676918A2 G-beta-gamma regulated phosphatidylinositol-3' kinase |
| 07/05/2006 | EP1676917A2 Novel human kinases and uses thereof |
| 07/05/2006 | EP1676912A2 Medical equipment containing a polypeptide having heparanase activity |
| 07/05/2006 | EP1676862A1 Recombinant antibody against human insulin-like growth factor |
| 07/05/2006 | EP1676856A1 Peptide originating in hepatitis c virus |
| 07/05/2006 | EP1676587A1 Pharmaceutical compositions for therapeutic use |
| 07/05/2006 | EP1676586A1 Method of separating rotavirus variants and live attenuated rotavirus vaccine |
| 07/05/2006 | EP1676132A1 System and method for the treatment of cancer, including cancers of the central nervous system |
| 07/05/2006 | EP1675942A2 Immunogenic composition and method of developing a vaccine based on cyclophilin a binding site |
| 07/05/2006 | EP1675869A2 Stabilised compositions |
| 07/05/2006 | EP1675614A2 Methods and compositions for enhancing innate immunity and antibody dependent cellular cytotoxicity |
| 07/05/2006 | EP1675613A2 Hiv vaccines based on env of multiple clades of hiv |
| 07/05/2006 | EP1675612A2 Immunogenic composition and method of developing a vaccine based on factor h binding sites |
| 07/05/2006 | EP1675609A1 Therapeutic regimens for baff antagonists |
| 07/05/2006 | EP1675607A2 Monomeric recombinant mhc molecules useful for manipulation of antigen-specific t cells |
| 07/05/2006 | EP1675596A2 Method |
| 07/05/2006 | EP1675589A2 Treatment of inflamed joints |
| 07/05/2006 | EP1675579A2 Human epo mimetic hinge core mimetibodies, compositions, methods and uses |
| 07/05/2006 | EP1675549A2 Educated nkt cells and their uses in the treatment of immune-related disorders |
| 07/05/2006 | EP1675547A2 Glucocerebroside treatment of disease |
| 07/05/2006 | EP1313762B1 Suppressor gene |
| 07/05/2006 | EP1274853B1 Materials and methods relating to immune responses to fusion proteins |
| 07/05/2006 | EP1235900B1 Microparticle-based transfection and activation of dendritic cells |
| 07/05/2006 | EP1210373B1 Congener independent detection of microcystin and nodularin congeners |
| 07/05/2006 | EP1161250B9 Immunostimulant bacterial membrane fractions in cancer treatment |
| 07/05/2006 | EP1102838B1 A method of modulating the efficiency of translation termination and degradation of aberrant mrna involving a surveillance complex comprising human upf1p, eucaryotic release factor 1 and eucaryotic release factor 3 |
| 07/05/2006 | EP1096955B9 Uses of antibodies to aminophospholipids for cancer treatment |
| 07/05/2006 | EP1015489B1 Dendritic cell receptor |
| 07/05/2006 | EP0923740B1 Methods and compositions for the detection of cervical cancer |
| 07/05/2006 | EP0721506B1 Bacterial exported proteins and acellular vaccines based thereon |
| 07/05/2006 | EP0702725B1 Method for recombinant production of biologically active polypeptides |
| 07/05/2006 | EP0695360B1 Defective recombinant adenoviruses for gene therapy of tumours |
| 07/05/2006 | CN1798844A Cell surface expression vector of SARS virus antigen and microorganisms transformed thereby |
| 07/05/2006 | CN1798842A 核酸检测 Nucleic acid detection |
| 07/05/2006 | CN1798840A NOGO receptor binding protein. |
| 07/05/2006 | CN1798834A Composition for stabilizing survival of transplanted hematopoietic stem cell, kit for obtaining the composition, method of stabilizing survivial of transplanted hematopoietic stem cell, human monoclon |
| 07/05/2006 | CN1798769A Antibodies to masp-2 |
| 07/05/2006 | CN1798766A Humanized antibodies that recognize beta amyloid peptide |
| 07/05/2006 | CN1798765A Multivalent lymphotoxin beta receptor agonists and therapeutic uses thereof |
| 07/05/2006 | CN1798762A Tuberculosis vaccine with improved efficacy. |
| 07/05/2006 | CN1798761A Enterococcus antigens |
| 07/05/2006 | CN1798760A Immunogenic compositions comprising venezuelan equine encephalitis virus replicon vectors and paramyxovirus protein antigens |
| 07/05/2006 | CN1798577A Method of inducing differentiation and proliferating regulatory t cell by anti-CD52 antibody and medicinal composition therefor |
| 07/05/2006 | CN1798575A 高浓度抗体和蛋白制剂 High concentrations of antibody and protein formulations |
| 07/05/2006 | CN1798574A Acapsular p. multocida hyae deletion mutants |
| 07/05/2006 | CN1798569A Therapeutic vaccine compositions for the treatment of type 1 diabetes |
| 07/05/2006 | CN1798548A Immunogenic compositions based on microparticles comprising adsorbed toxoid and a polysaccharide-containing antigen |
| 07/05/2006 | CN1796565A Recombined virus for expressing spike protein of SARS coronavirus and preparation method |
| 07/05/2006 | CN1796564A Recombined virus for expressing nucleoprotein of SARS coronavirus and preparation method |
| 07/05/2006 | CN1796558A Isolated nucleic acid molecules which encode T cell inducible factors, or interleukin-21, the proteins encoded, and uses thereof |
| 07/05/2006 | CN1796416A Immunoglobulin for anti virus of poultry influenza, preparation method and preparation |
| 07/05/2006 | CN1796404A Neisserial antigenic peptides |
| 07/05/2006 | CN1796403A Polypeptide and bacterin in use for preventing and curing infection of polytype human being papilomavirus |
| 07/05/2006 | CN1262665C Code-optimized papilloma virus sequences |
| 07/05/2006 | CN1262664C Recombined procine adenovirus based on viral vaccines and vectors |
| 07/05/2006 | CN1262650C Tissue cement proteins from rhipicephalus appendiculatus |
| 07/05/2006 | CN1262643C Monocolone antibody, encoding gene, its uses and hybrid nodule cell line for cecreting same |
| 07/05/2006 | CN1262565C Recombinant fusion protein for diagnosis of tsutsugamushi disease |
| 07/05/2006 | CN1262558C Nucleotide specific for escherichia coli 0151 O-antigen |
| 07/04/2006 | US7071344 Vitamin D derivatives with cyclopropyl rings in the lateral chains, a method and intermediate products for the production thereof and the utilization thereof for producing medicaments |
| 07/04/2006 | US7071321 Identifying a BASB033 polypeptide or an antibody that is immunospecific for such polypeptide, present with in a biological sample form the animal suspected having meningococcus induced infections and meningitis |
| 07/04/2006 | US7071320 Desaturase antigen of mycobacterium tuberculosis |
| 07/04/2006 | US7071316 Human Akt-3 |
| 07/04/2006 | US7071312 Epidermal differentiation factor |
| 07/04/2006 | US7071311 Antibodies having specificity for 2′-C-allyl nucleic acids |
| 07/04/2006 | US7071309 Determination metastasis using protein |
| 07/04/2006 | US7071300 IGF antagonist peptides |
| 07/04/2006 | US7071296 vaccines against malaria comprising epitopes contained within merozoite surface proteins (MSP) or polypeptides, and carriers such as alums and/or freund's adjuvants; inoculation; immunology |
| 07/04/2006 | US7071172 Secretion signal vectors |
| 07/04/2006 | US7070998 Supplying Dna to cells; genetic engineering genomes; therapy for central nervous system diosrders |
| 07/04/2006 | US7070994 genetic engineered retrovirus; from transgenic animals; drug transport |
| 07/04/2006 | US7070977 Human serine protease D-G polypeptide |
| 07/04/2006 | US7070972 Isolated polynucleotide; catalyst; transformation lymphocytes; antibodies; detecting therapy agents |
| 07/04/2006 | US7070971 enzyme inhibitor for selectin mediated binding events and methods of treating disease conditions using animal models; genetic engineering |
| 07/04/2006 | US7070969 Plasmin inhibitors from the australian brown snake Pseudonaja textilis textilis |
| 07/04/2006 | US7070793 Antigen protein and nucleic acid coding for said protein |
| 07/04/2006 | US7070792 Chlamydia antigens and corresponding DNA fragments and uses thereof |
| 07/04/2006 | US7070791 Comprises genetically engineered bacteriophage polymerase for detection and treatment of microorganismal infections |
| 07/04/2006 | US7070790 peptides and recombinant envelope 1 and core proteins derived from specific gene sequences and their use in diagnostic methods and vaccines. |
| 07/04/2006 | US7070789 Hybrid polypeptides as vaccine |
| 07/04/2006 | US7070787 Relates to immunogen for inducing antibodies that neutralize a wide spectrum of HIV primary isolates and method of inducing anti-HIV antibodies using such immunogen |